Impact of regional guidelines on the management of urinary tract infections with antibiotics;Impact d'un guide régional pour la prise en charge des infections urinaires sur les pratiques d'antibiothérapies

Medecine et Maladies Infectieuses

Volumn 40, Issue 6, 2010, Pages 352-357

  Ruyer, O ^a   Slekovec, C ^b   Bertrand, X ^b   Faller, J P ^a   Hoen, B ^b   Talon, D ^b   Leroy, J ^b  

^a Centre Hospitalier Belfort Montbeliard   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Antibiotic prescription; Fluoroquinolones; Fosfomycin; Urinary tract infection

Indexed keywords

CIPROFLOXACIN; FOSFOMYCIN; LOMEFLOXACIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; ASYMPTOMATIC BACTERIURIA; COMORBIDITY; CYSTITIS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG USE; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; SINGLE DRUG DOSE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; DISEASE MANAGEMENT; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; FLUOROQUINOLONES; FOSFOMYCIN; FRANCE; GUIDELINE ADHERENCE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; NITROFURANTOIN; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 77953809513     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2010.01.006     Document Type: Article

References (24)

1. Van Bambeke F., Michot J.M., Van Eldere J., Tulkens P.M. Quinolones in 2005: An update. Clin Microbiol Infect 2005, 11:256-280.
2. Goossens H., Ferech M., Vander Stichele R., Elseviers M. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005, 365:579-587.
3. Zervos M.J., Hershberger E., Nicolau D.P., Ritchie D.J., Blackner L.K., Coyle E.A., et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003, 37:1643-1648.
4. Charbonneau P., Parienti J.J., Thibon P., Ramakers M., Daubin C., du Cheyron D., et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: A quasi experimental study. Clin Infect Dis 2006, 42:778-784.
5. Bon usage de l'antibiothérapie en Franche-Comté. Infections urinaires de l'adulte. 2008. Disponible sur: (1 juin 2009). http://www.fcsante.fr/rfclin/doc_primair/Bon_usage_de_l_antibiotherapie_en_FC.pdf.
6. Ministère de la santé. Disponible sur: (1 juin 2009). http://www.sante.gouv.fr/htm/dossiers/calcul_antibiotiques/sommaire.htm.
7. Apisarnthanarak A., Danchaivijitr S., Khawcharoenporn T., Limsrivilai J., Warachan B., Bailey T.C., et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006, 42:768-775.
8. Lallemand De Conto S., Bretl E., Huc B., Picard A., Tuefferd N., Talon D. Long-term usefulness of an information programme on practices in surgical antimicrobial prophylaxis. Ann Chir 2003, 128:438-446.
9. Carpenter C.E., Johnson N.E., Rosenfeld J.F. The impact of clinical guidelines on practice patterns: Doing more versus doing less. Am J Med Qual 1998, 13:98-103.
10. Smith W.R. Evidence for the effectiveness of techniques to change physician behavior. Chest 2000, 118:8S-17S.
11. Jiang H.J., Lagasse R.S., Ciccone K., Jakubowski M.S., Kitain E.M. Factors influencing hospital implementation of acute pain management practice guidelines. J Clin Anesth 2001, 13:268-276.
12. Christakis D.A., Rivara F.P. Pediatricians' awareness of and attitudes about four clinical practice guidelines. Pediatrics 1998, 101:825-830.
13. Bero L.A., Grilli R., Grimshaw J.M., Harvey E., Oxman A.D., Thomson M.A. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings, The Cochrane Effective Practice and Organization of Care Review Group. BMJ 1998, 317:465-468.
14. Monnet D.L., Lopez-Lozano J.M. Relationship between antibiotic consumption and resistance in European hospitals. Med Mal Infect 2005, 35(Suppl 2):S127-S128.
15. Ena J., Lopez-Perezagua M.M., Martinez-Peinado C., Cia-Barrio M.A., Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 1998, 30:103-107.
16. Trystram D., Grenet K., Cambau E., Pean Y., Fievet M.H., Jarlier V., et al. Evolution of susceptibility of aerobic gram-negative aerobic bacilli to quinolones and fluoroquinolones in a university hospital (1992-2000). Pathol Biol 2002, 50:30-37.
17. Hooper D.C. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2002, 2:530-538.
18. Bishai W. Current issues on resistance, treatment guidelines, and the appropriate use of fluoroquinolones for respiratory tract infections. Clin Ther 2002, 24:838-850.
19. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., Karam G., Quinn J.P. Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use. JAMA 2003, 289:885-888.
20. Lautenbach E., Fishman N.O., Bilker W.B., Castiglioni A., Metlay J.P., Edelstein P.H., et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 2002, 162:2469-2477.
21. Ho P.L., Tse W.S., Tsang K.W., Kwok T.K., Ng T.K., Cheng V.C., et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study. Clin Infect Dis 2001, 32:701-707.
22. Anderson K.B., Tan J.S., File T.M., DiPersio J.R., Willey B.M., Low D.E. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. Clin Infect Dis 2003, 37:376-381.
23. Hooper D.C. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001, 7:337-341.
24. Scheld W.M. Maintaining fluoroquinolone class efficacy: Review of influencing factors. Emerg Infect Dis 2003, 9:1-9.